Skip to main content

Table 6 The predicted ncRNAs related to the six diseases examined in this study

From: ncRNA-disease association prediction based on sequence information and tripartite network

Disease

ncRNA

Evidence (PMID)

Breast

Neoplasms

H19

15985428;27540977;9811352;24780616

Breast

Neoplasms

PVT1

17908964;10485452;23907597

Breast

Neoplasms

SRA1

17710122;26460974

Breast

Neoplasms

WRAP53

27525856;15736456

Carcinoma, Hepatocellular

H19

9570364

Carcinoma, Hepatocellular

PCNA-AS1

24704293

Carcinoma, Hepatocellular

WRAP53

23836507

Lung

Neoplasms

HOTAIR

25010625;22088988

Lung

Neoplasms

MALAT1

23243023;26490983

Lung

Neoplasms

PVT1

25400777

Lung

Neoplasms

XIST

26339353

 Prostatic Neoplasms

CDKN2B-AS1

27197191;24988946

 Prostatic Neoplasms

H19

19513555;25895025

 Prostatic Neoplasms

HOTAIR

26411689

 Prostatic Neoplasms

MALAT1

23845456

 Prostatic Neoplasms

PCAT1

21804560

 Prostatic Neoplasms

SRA1

16607388

 Prostatic Neoplasms

XIST

16261845

 Stomach Neoplasms

CDKN2B-AS1

24810364;26187665

 Stomach Neoplasms

HOTAIR

25063030;23898077

 Stomach Neoplasms

MALAT1

24857172

Urinary Bladder Neoplasms

H19

23354591

Urinary Bladder Neoplasms

WRAP53

27912092

  1. The predicted ncRNAs related to lung cancer, liver cancer, breast cancer, urinary bladder neoplasms, prostatic neoplasms and stomach neoplasms based upon our method. Each research article reporting on a specific ncRNA is shown with a unique ID (PMID) by PubMed